What Is Cluster Headache?
Cluster headache is a primary headache classified in the group of trigeminal autonomic cephalalgias. It is considered one of the most intense pains known in medicine — frequently described as an excruciating pain, "as if a red-hot object were being pressed against the eye."
The name "cluster" reflects the characteristic temporal pattern: attacks occur in cluster periods that last weeks to months, interspersed with periods of remission that can last months to years. During a cluster, the patient has 1 to 8 attacks per day, frequently at predictable times.
Unlike migraine, cluster headache is more common in men (3-4:1) and typically begins between the ages of 20 and 40. Despite its extraordinary intensity, it is often underdiagnosed, averaging 5-7 years before the correct diagnosis is made.
Excruciating Pain
Classified as one of the most intense pains in medicine. Patients frequently cannot remain still during attacks.
Temporal Pattern
Attacks cluster in periods following a circadian rhythm — often at the same time each day, frequently waking the patient in the early morning.
Hypothalamic Origin
The hypothalamus is the central generator of attacks, explaining the characteristic circadian and seasonal rhythmicity.
Pathophysiology
Cluster headache is a hypothalamic disease with secondary activation of the trigeminovascular system and the parasympathetic autonomic pathway. The posterior hypothalamus functions as the "biological clock" that triggers attacks with predictable temporal patterns.
Functional neuroimaging studies (PET and fMRI) have demonstrated activation of the ipsilateral posteroinferior hypothalamus during attacks — a landmark discovery that grounded the modern understanding of the disease. This region contains the suprachiasmatic nucleus, responsible for circadian rhythms.
The Trigeminoautonomic Reflex
Activation of the ophthalmic branch of the trigeminal nerve (V1) produces the intense periorbital pain. At the same time, parasympathetic fibers of the facial nerve are activated via the trigeminoautonomic reflex, causing the ipsilateral autonomic symptoms: lacrimation, nasal congestion, rhinorrhea, eyelid edema, and miosis/ptosis.
CGRP and VIP (vasoactive intestinal peptide) are significantly elevated during attacks. CGRP is released by the trigeminal fibers, while VIP reflects parasympathetic activation. Levels normalize after effective treatment with sumatriptan or oxygen.
Symptoms
A cluster headache attack is unmistakable: excruciating unilateral pain combined with ipsilateral autonomic symptoms and motor agitation. Recognizing this pattern is fundamental for distinguishing it from other headaches.
Symptoms of a Cluster Headache Attack
- 01
Excruciating unilateral periorbital/temporal pain
Intense pain around or behind one eye that may radiate to the face, jaw, and neck. Always on the same side during a cluster.
- 02
Ipsilateral lacrimation
Profuse tearing in the eye on the pain side, present in more than 90% of patients.
- 03
Ipsilateral nasal congestion or rhinorrhea
Nasal obstruction or watery discharge on the pain side, often mistaken for sinusitis.
- 04
Ipsilateral ptosis and miosis
Drooping eyelid and constricted pupil (partial Horner syndrome), reflecting ipsilateral sympathetic dysfunction.
- 05
Eyelid edema
Swelling of the eyelid on the affected side, present in up to 74% of patients.
- 06
Psychomotor agitation
Unlike migraine, the patient cannot stay still — they pace, rock, and press the painful area. An inability to keep still.
- 07
Duration of 15-180 minutes
Attacks typically last 45-90 minutes. Abrupt onset and offset.
- 08
Circadian rhythmicity
Attacks often occur at the same time each day, especially 1-2 hours after falling asleep (REM sleep phase).
Diagnosis
Diagnosis is clinical, based on the typical history of intense, brief periorbital/temporal pain attacks with ipsilateral autonomic symptoms. Despite the classic clinical picture, the average diagnostic delay is 5-7 years, often due to confusion with sinusitis, migraine, or dental problems.
🏥ICHD-3 Criteria for Cluster Headache
- 1.At least 5 attacks meeting the criteria below
- 2.Severe to very severe unilateral orbital/supraorbital/temporal pain, lasting 15-180 minutes
- 3.At least 1 of: ipsilateral lacrimation/conjunctival injection, ipsilateral nasal congestion/rhinorrhea, ipsilateral eyelid edema, ipsilateral forehead/facial sweating, ipsilateral miosis/ptosis, agitation or restlessness
- 4.Frequency of 1 every 2 days up to 8 per day
- 5.Not attributed to another condition
Differential Diagnosis
Cluster headache shares features with other primary and secondary headaches that require careful distinction. The average 5-7 year diagnostic delay is largely due to confusion with other conditions.
DIAGNÓSTICO DIFERENCIAL
Differential Diagnosis
Migraine
Read more →- Duration 4-72 h (longer)
- No lacrimation/ptosis
- Bilateral possible
- Intense photophobia
Testes Diagnósticos
- ICHD-3 criteria
Paroxysmal Hemicrania
- Episodes of 2-30 min
- Female predominance
- Dramatic response to indomethacin
Testes Diagnósticos
- Therapeutic trial with indomethacin
SUNCT/SUNA
- Episodes of seconds to a few minutes
- Conjunctival injection and lacrimation
- Very high daily frequency
Testes Diagnósticos
- ICHD-3 criteria
- MRI to rule out secondary cause
Trigeminal Neuralgia
Read more →- Duration of seconds
- Facial trigger zone
- No autonomic symptoms
Testes Diagnósticos
- ICHD-3 criteria
- Contrast MRI
Sinusitis
- Facial pain with nasal congestion
- Sinus tenderness on percussion
- Possible fever
Testes Diagnósticos
- Sinus CT
The Most Common Mistake: Confusion with Sinusitis
Confusion with sinusitis is the main cause of diagnostic delay in cluster headache. The nasal congestion and lacrimation — autonomic symptoms of the attack — are interpreted as acute sinusitis, and the patient receives repeated courses of antibiotics without benefit. The key difference: in cluster headache, nasal symptoms are ipsilateral to the pain, appear abruptly with attacks, and resolve with them, whereas in sinusitis nasal symptoms are persistent and the pain is more diffuse and dull.
Any physician evaluating patients with "recurrent sinusitis" that does not respond to antibiotics should actively ask about the temporal pattern of attacks, strict unilaterality of the pain, and presence of lacrimation, ptosis, or agitation. When present, these features indicate cluster headache until proven otherwise.
Trigeminal Autonomic Cephalalgias: The Cluster Headache Family
Cluster headache belongs to the trigeminal autonomic cephalalgias (TACs), which share activation of the trigeminoautonomic reflex. The other TACs — paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua — present similar autonomic symptoms but differ in duration, frequency, and therapeutic response. This distinction is clinically critical because TACs respond to different treatments.
Paroxysmal hemicrania, for example, is clinically similar to cluster headache but has an absolute and specific response to indomethacin — its absence rules out the diagnosis. SUNCT presents with much shorter attacks (seconds to 2 minutes) and very high frequency (up to 200 attacks per day), responsive to lamotrigine. MRI is mandatory in all TACs to rule out secondary causes.
When to Suspect a Secondary Cause
Although most cluster headaches are primary, secondary causes should be ruled out in every case, especially at first presentation. Pituitary tumors, meningiomas, arteriovenous malformations, and cerebral aneurysms can cause a cluster headache-like syndrome by compressing structures adjacent to the hypothalamus or cavernous sinus.
Red flags suggesting a secondary cause include: onset after age 50 without prior history, absence of the typical circadian pattern, associated neurologic signs, clusters unresponsive to standard treatment, and bilateral cluster headache. Contrast brain MRI is indicated in all patients at diagnosis.
Treatment
Cluster headache treatment includes three components: abortive treatment (to terminate the attack rapidly), transitional treatment (for rapid suppression of attacks while the preventive takes effect), and preventive treatment (to shorten the cluster and reduce attack frequency).
THERAPEUTIC OPTIONS IN CLUSTER HEADACHE
| TYPE | MEDICATION | EFFICACY/OBSERVATIONS |
|---|---|---|
| Abortive | 100% Oxygen (12-15 L/min for 15 min) | First-line treatment in controlled studies; well tolerated, but should be used under medical supervision. |
| Abortive | Sumatriptan 6 mg subcutaneous | Effective in 75% of patients within 15 minutes. Contraindicated in cardiovascular disease. |
| Transitional | Corticosteroids (prednisone) | Short course of 2-3 weeks for rapid attack suppression. |
| Preventive | Verapamil (240-960 mg/day) | First line in prevention. Requires ECG monitoring. |
| Preventive | Lithium (600-1200 mg/day) | Second-line treatment. Requires monitoring of lithium levels and thyroid function. |
| Preventive | Anti-CGRP antibodies (galcanezumab) | Approved for episodic cluster headache. New therapeutic advance. |
Abortive Treatment
100% oxygen by non-rebreather mask at 12-15 L/min for 15-20 minutes is considered first-line treatment to abort attacks in controlled studies. It is generally well tolerated and can be used multiple times per day under medical supervision. It should be formally prescribed so the patient has home access.
Subcutaneous sumatriptan (6 mg) is the most rapid alternative, with relief in 15 minutes for most patients. Nasal sumatriptan (20 mg) is a less invasive option, although somewhat less effective. Common analgesics and anti-inflammatories are ineffective — the attack ends before they reach therapeutic concentrations.
Acupuncture as Treatment
Evidence for acupuncture in cluster headache is more limited than for migraine, with few large-scale randomized clinical trials. However, some studies and case series suggest acupuncture may play an adjunctive role, particularly during the cluster phase and in preventing recurrences.
Proposed mechanisms include modulation of hypothalamic activity, regulation of the trigeminoautonomic system, effects on CGRP levels, and modulation of the autonomic nervous system. Stimulating points in the craniofacial and cervical regions can influence the trigeminovascular pathways involved in attack generation.
It is important to emphasize that acupuncture does not replace established pharmacologic treatment in cluster headache, especially oxygen and sumatriptan for acute attacks. It can be considered a complementary therapy alongside standard preventive treatment, particularly in patients with a partial response to medications.
Prognosis
Cluster headache is a chronic condition with a variable course. In the episodic form (80-90% of cases), cluster periods typically last 2-12 weeks and recur once or twice a year, with full remission between clusters.
About 10-20% of patients present the chronic form, in which remissions are absent or last less than 3 months. Transition from episodic to chronic can occur over time, although the reverse is also possible.
With appropriate treatment, most patients achieve significant control of attacks during cluster periods. In a minority, cluster headache may enter prolonged or permanent remission with age.
Myths and Facts
Myth vs. Fact
Cluster headache is a type of migraine
They are entirely distinct conditions. Cluster headache belongs to the trigeminal autonomic cephalalgias, with different pathophysiology, symptoms, and treatments.
It is caused by sinusitis
Nasal congestion is an autonomic symptom of the attack, not its cause. This confusion leads to years of incorrect treatment in many patients.
Common analgesics resolve the pain
Oral analgesics are ineffective — the attack ends spontaneously before they take effect. 100% oxygen and subcutaneous sumatriptan are the effective abortive treatments.
Only men develop cluster headache
Although more common in men (3-4:1), women are also affected. In women, diagnosis is often even more delayed because it is mistaken for migraine.
When to Seek Help
Frequently Asked Questions
Frequently Asked Questions
Cluster headache is consistently classified as one of the most intense pains that a human being can experience — many patients report that it is more intense than bone fracture, childbirth without anesthesia, or burns. This led cluster headache to be informally called "suicide headache," a name that reflects the devastating impact it can have without adequate treatment. With correct treatment, most patients achieve satisfactory control of attacks.
Circadian rhythmicity — attacks at the same time, frequently early morning — reflects the central hypothalamic dysfunction in the disease. The posterior hypothalamus, which contains the suprachiasmatic nucleus (the body’s "biological clock"), is the central generator of attacks. Neuroimaging studies have demonstrated activation of this region during attacks. Alterations in melatonin and cortisol levels during cluster periods reinforce the role of the hypothalamus.
100% oxygen via non-rebreather mask at 12-15 L/min for 15-20 minutes is considered first-line treatment for aborting attacks in controlled studies. It is generally well tolerated and can be used several times a day under medical supervision. Subcutaneous sumatriptan 6 mg is the fastest alternative, with most patients reporting relief in about 15 minutes, and is indicated when oxygen is unavailable or insufficient. Common analgesics and anti-inflammatories are ineffective.
Verapamil (240-960 mg/day) is the first-line preventive during clusters. It requires ECG monitoring due to the risk of cardiac block. A short course of corticosteroids (prednisone) is used as a bridge — rapidly suppressing attacks while verapamil reaches therapeutic levels. Lithium is a second-line option, especially for the chronic form. Anti-CGRP antibodies (galcanezumab) have been approved for episodic cluster headache.
In a minority of patients, cluster headache may enter prolonged or permanent remission with age. In the episodic form (80-90% of cases), complete remission between clusters is the rule and can last months to years. In the chronic form (10-20%), remissions are absent or very brief. Some patients with the chronic form can convert to the episodic form with appropriate treatment, especially with anti-CGRP antibodies.
Yes, alcohol is one of the most potent triggers during a cluster period — even small amounts can provoke an attack within minutes to hours. The mechanism involves vasodilation and possible hypothalamic activation. Notably, the same patient can drink alcohol freely during remission periods without triggering an attack. Smoking is an established risk factor for developing the disease, and most patients with cluster headache are or were smokers.
Evidence for acupuncture in cluster headache is more limited than for migraine. Preliminary studies suggest it may play an adjunctive role in reducing attack frequency and shortening cluster periods, but it does not replace established pharmacologic treatment. The medical acupuncturist may consider acupuncture as a complement to standard preventive treatment, especially in patients with a partial response to verapamil or those seeking to reduce their drug dose.
Cluster headache is three to four times more common in men than in women — a prevalence inversion relative to migraine, which is more common in women. The reasons are not fully understood but include hormonal differences, the role of smoking (historically more prevalent in men), and possibly differences in hypothalamic anatomy and function between the sexes. In women, diagnosis is often even more delayed because the condition is mistaken for migraine.
During an attack: use 100% oxygen if available at home (as prescribed by the physician), administer subcutaneous sumatriptan if prescribed, and avoid lying down — patients naturally tend to stand or move, the opposite of migraine. Do not take oral analgesics; the attack ends before they take effect. Attacks typically last 45-90 minutes and subside on their own. Recording the time and duration of attacks helps the physician adjust preventive treatment.
Cluster headache in children is rare but documented. Typical onset is in the second or third decade of life, peaking between ages 20 and 40. Pediatric cases tend to be underdiagnosed, since the condition is poorly recognized outside neurology. Presentation in children can differ slightly from adults, with shorter attacks and perhaps less prominent autonomic symptoms. Any child with recurrent unilateral periorbital pain should be evaluated by a neurologist.
Related Reading
Deepen your knowledge with related articles